Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 10 OF 86 | DISPLAYING 136 - 150 OF 1287 RESULTS

    Kim RD et al., First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma, , Cancer Discovery, Oct 01, 2019

    Tannenbaum CS et al., Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs, , Cancer Immunol Res, Oct 01, 2019

    Wettersten HI et al., Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression., , Cancer Res, Oct 01, 2019

    Yang H et al., STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade., , J Clin Invest, Oct 01, 2019

    Fakih M et al., Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome., , J Clin Invest, Oct 01, 2019

    Annels NE et al., Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer, , Clin Cancer Res, Oct 01, 2019

    Lee J et al., Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial, , Cancer Discovery, Oct 01, 2019

    Renner K et al., Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy., , Cell Rep, Oct 01, 2019

    Aushev V et al., Tumor expression of environmental chemical-responsive genes and breast cancer mortality., , Endocr Relat Cancer, Oct 01, 2019

    Kaur G et al., Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development., , Asian Pac J Cancer Prev, Oct 01, 2019

    Lee O et al., Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate., , Clin Cancer Res, Sep 30, 2019

    Dong J et al., Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications., , Adv Mater, Sep 30, 2019

    Halse H et al., A distinct pre-treatment immune gene signature in lentigo maligna is associated with imiquimod response, , J Invest Dermatol., Sep 30, 2019

    Flesher JL et al., Delineating the role of MITF isoforms in pigmentation and tissue homeostasis, , Pigment Cell Melanoma Res., Sep 28, 2019

    López‐Sánchez LM et al., SWATH‐based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours., , J Cell Mol Med, Sep 27, 2019